About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Hnf1btm1Mya
targeted mutation 1, Moshe Yaniv
MGI:1857866
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Hnf1btm1Mya/Hnf1btm1Mya involves: 129S2/SvPas MGI:2672788
cn2
Hnf1btm1Mya/Hnf1btm3Mya
Tg(Alb1-cre)7Gsc/0
involves: 129S2/SvPas * C57BL/6 * FVB/N MGI:2670940


Genotype
MGI:2672788
hm1
Allelic
Composition
Hnf1btm1Mya/Hnf1btm1Mya
Genetic
Background
involves: 129S2/SvPas
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hnf1btm1Mya mutation (0 available); any Hnf1b mutation (16 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• no live homozygous mutant embryos are obtained after E7.5
• only resorbed tissues are detected after E8.5

embryo
• at E7.5, homozygotes display no signs of gastrulation, although some embryos are able to undergo cavitation
• at E7.5, mutant embryonic tissues are highly degenerated or disorganized, resembling a mass of undifferentiated cells surrounded by trophoblastic tissues
• although morphologically normal up to E6.5, mutant embryos appear significantly smaller than wild-type embryos at E7.5
• at E7.5, all homozygotes display embryonic tissue disorganization of variable severity
• some mutant embryos fail to undergo cavitation by E7.5
• at E7.5, all homozygotes display extraembryonic tissue disorganization of variable severity
• at E7.5, homozygotes exhibit impaired visceral endoderm specialization, as shown by loss of late endodermal marker expression, absence of columnar epithelial cells, and a uniform cuboidal cell morphology reminiscent of E6.5 embryos
• in culture, mutant ES cells fail to fully differentiate into visceral endoderm, as shown by loss of late endodermal marker expression

growth/size/body
• although morphologically normal up to E6.5, mutant embryos appear significantly smaller than wild-type embryos at E7.5




Genotype
MGI:2670940
cn2
Allelic
Composition
Hnf1btm1Mya/Hnf1btm3Mya
Tg(Alb1-cre)7Gsc/0
Genetic
Background
involves: 129S2/SvPas * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Hnf1btm1Mya mutation (0 available); any Hnf1b mutation (16 available)
Hnf1btm3Mya mutation (0 available); any Hnf1b mutation (16 available)
Tg(Alb1-cre)7Gsc mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• at 2 months, mutant livers display hepatocyte necrosis and oval cell proliferation

mortality/aging
• despite the severity of their phenotype, most mutant mice survive for several months

liver/biliary system
• mutants exhibit abnormal intrahepatic bile duct (IHBD) differentiation and morphogenesis, resulting in persistence of the ductal plate and a highly disorganized biliary system
• in addition, mutant livers show absence of interlobular arteries in portal tracts, suggesting a link between arterial and biliary development within the liver
• at 2 months, mutant livers display hepatocyte necrosis and oval cell proliferation
• at 2 months, mutant extrahepatic biliary tracts display epithelial abnormalities
• in extreme cases, the cystic duct is completely dilated and no duct is clearly identifiable
• at 2 months, mutants exhibit dysplasia of the larger intrahepatic bile ducts (IHBDs) and a reduction, or paucity, of small IHBDs
• absence of identifiable IHBDs is already evident at P7, indicating lack of formation of interlobular bile ducts
• at 2 months, mutant gallbladders exhibit epithelial dysplasia
• in the mutant gallbladder, the normal cuboidal epithelium is replaced in some areas by a stratified squamous epithelium or mucus-secreting cells
• nonetheless, mutant gallbladders are filled with bile and communicate with the liver and the duodenum
• mutant mice exhibit fully penetrant liver hypertrophy
• at 2 months, mutant mice exhibit liver inflammation
• mutant mice exhibit fully penetrant chronic jaundice

homeostasis/metabolism
• as early as P7, mutant mice show increased plasma levels of bilirubin
• by 2 months, mutant bilirubin and bile acid levels are dramatically increased
• as early as P7, mutants exhibit significantly increased levels of serum cholesterol; levels become stabilized after P14
• as early as P7, mutants exhibit significantly increased levels of serum triglycerides, suggesting altered hepatocyte metabolism; levels become stabilized after P14

growth/size/body
• body weight differences are detected as early as P2 and increase with time, reaching a growth plateau at weaning
• mutant mice display severe postnatal growth retardation
• mutant mice exhibit fully penetrant liver hypertrophy

muscle

immune system
• at 2 months, mutant mice exhibit liver inflammation

endocrine/exocrine glands
• at 2 months, mutant extrahepatic biliary tracts display epithelial abnormalities
• in extreme cases, the cystic duct is completely dilated and no duct is clearly identifiable
• at 2 months, mutants exhibit dysplasia of the larger intrahepatic bile ducts (IHBDs) and a reduction, or paucity, of small IHBDs
• absence of identifiable IHBDs is already evident at P7, indicating lack of formation of interlobular bile ducts
• at 2 months, mutant gallbladders exhibit epithelial dysplasia
• in the mutant gallbladder, the normal cuboidal epithelium is replaced in some areas by a stratified squamous epithelium or mucus-secreting cells
• nonetheless, mutant gallbladders are filled with bile and communicate with the liver and the duodenum





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/23/2024
MGI 6.23
The Jackson Laboratory